Approval · Notice of Compliance 1900 · 1999
NU-LOVASTATIN: Notice of Compliance 1900
Issued April 20, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1900
- Date
- April 20, 1999
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-LOVASTATIN | 02231434 | Cancelled Post Market |
| NU-LOVASTATIN | 02231435 | — |
Medicinal ingredients
- LOVASTATIN 20 MG per TAB
- LOVASTATIN 40 MG per TAB